Leadership Overview
Astellas Pharma has 10 executives leading key functions including financial strategy, strategic collaboration, marketing analytics, operational management, manufacturing integration, research development, human resources, enterprise programs, executive administration, and regional market expansion.
Focused on advancing global health, Astellas Pharma delivers innovative pharmaceutical solutions through rigorous manufacturing standards and a commitment to improving patient outcomes across international markets.
Focused on advancing global health, Astellas Pharma delivers innovative pharmaceutical solutions through rigorous manufacturing standards and a commitment to improving patient outcomes across international markets.
Leadership Roles at Astellas Pharma
Atsushi Kitamura - Chief Financial Officer
Atsushi Kitamura, the Chief Financial Officer at Astellas Pharma, directs the global financial strategy and fiscal health of the organization. Overseeing capital allocation, the Chief Financial Officer ensures that investment in pharmaceutical research aligns with long-term profitability goals. This leadership role involves managing complex budgetary frameworks across international manufacturing sites to maintain operational efficiency. By optimizing financial reporting systems, Atsushi Kitamura directly impacts the ability of the company to scale production capabilities. Furthermore, the Chief Financial Officer coordinates with the board to mitigate fiscal risks associated with global drug development cycles. Through rigorous oversight of balance sheets and investment portfolios, the Chief Financial Officer secures the necessary resources to support the mission of delivering life-saving medications to patients worldwide. Financial stability remains the primary objective for Kitamura while navigating the volatile pharmaceutical landscape.
Ruibo Tang - Senior Secretary To President
Ruibo Tang, the Senior Secretary To President at Astellas Pharma, directs the administrative flow and executive communication for the office of the President. Overseeing the daily operations of the executive suite, the Senior Secretary To President ensures that the President remains focused on high-level strategic decision-making. This leadership role involves managing complex scheduling, correspondence, and stakeholder interactions to maintain organizational momentum. By facilitating efficient communication between the President and other C-suite leaders, Ruibo Tang directly impacts the speed of corporate governance. Furthermore, the Senior Secretary To President coordinates executive meetings and prepares critical documentation for board reviews. Through the management of executive priorities, the Senior Secretary To President supports the overall mission of the company. Tang maintains a focus on operational precision to ensure that the leadership team functions effectively while navigating the complexities of the global pharmaceutical market.
Samuel Mantilha - Country President and General Manager - South Cone Cluster and LATAM Partnership Markets
Samuel Mantilha, the Country President and General Manager - South Cone Cluster and LATAM Partnership Markets at Astellas Pharma, directs regional operations and market expansion across South America. Overseeing the South Cone cluster, the Country President and General Manager - South Cone Cluster and LATAM Partnership Markets ensures that pharmaceutical products reach patients through effective local partnerships. This leadership role involves managing regulatory compliance and commercial growth in diverse LATAM markets. By driving regional initiatives, Samuel Mantilha directly impacts the market share of the company in these critical territories. Furthermore, the Country President and General Manager - South Cone Cluster and LATAM Partnership Markets collaborates with global leadership to adapt strategies for local market nuances. Through the management of regional partnerships, the Country President and General Manager - South Cone Cluster and LATAM Partnership Markets secures a strong presence in the region. Mantilha maintains a focus on sustainable growth and patient access.
Sand'Eria Lewis - Head of Strategic Collaboration Chief of Staff
Sand'Eria Lewis, the Head of Strategic Collaboration Chief of Staff at Astellas Pharma, architects high-level partnerships to accelerate drug discovery and market penetration. Overseeing cross-functional alliances, the Head of Strategic Collaboration Chief of Staff ensures that external research collaborations integrate seamlessly with internal development pipelines. This leadership role involves managing complex stakeholder relationships to drive innovation in pharmaceutical manufacturing. By aligning collaborative efforts with corporate objectives, Sand'Eria Lewis directly impacts the speed at which new therapies reach clinical trials. Furthermore, the Head of Strategic Collaboration Chief of Staff facilitates communication between executive leadership and external scientific partners to streamline decision-making processes. Through the cultivation of strategic networks, the Head of Strategic Collaboration Chief of Staff expands the reach of the company into emerging therapeutic areas. Lewis maintains a focus on sustainable growth through these vital industry connections.
Dhanush Adiga - Chief Marketing Officer, Lead Office (Reporting & Analytics)
Dhanush Adiga, the Chief Marketing Officer, Lead Office (Reporting & Analytics) at Astellas Pharma, directs data-driven marketing strategies to optimize product positioning. Overseeing advanced reporting and analytics, the Chief Marketing Officer, Lead Office (Reporting & Analytics) ensures that market insights inform every stage of the pharmaceutical lifecycle. This leadership role involves analyzing consumer trends and clinical data to refine outreach efforts across global markets. By leveraging sophisticated analytics, Dhanush Adiga directly impacts the effectiveness of commercial campaigns and brand visibility. Furthermore, the Chief Marketing Officer, Lead Office (Reporting & Analytics) collaborates with regional teams to tailor messaging for diverse patient populations. Through the implementation of robust data frameworks, the Chief Marketing Officer, Lead Office (Reporting & Analytics) enhances the precision of market engagement. Adiga drives competitive advantage by transforming complex datasets into actionable commercial intelligence for the entire organization.
Masaki Kubota - Manager, Chief Marketing Officer Office, Strategic Operations
Masaki Kubota, the Manager, Chief Marketing Officer Office, Strategic Operations at Astellas Pharma, executes operational workflows that support the commercialization of pharmaceutical products. Overseeing strategic operations, the Manager, Chief Marketing Officer Office, Strategic Operations ensures that marketing initiatives remain aligned with manufacturing output and supply chain capabilities. This leadership role involves coordinating internal resources to facilitate the launch of new therapies in competitive markets. By streamlining administrative processes within the marketing division, Masaki Kubota directly impacts the efficiency of global product rollouts. Furthermore, the Manager, Chief Marketing Officer Office, Strategic Operations manages the integration of operational data to support executive decision-making. Through the optimization of internal systems, the Manager, Chief Marketing Officer Office, Strategic Operations fosters a culture of agility and responsiveness. Kubota maintains a focus on operational excellence to ensure that marketing strategies translate into tangible market success.
Matthew Brieger - Chief Marketing Officer & Manager, External Manufacturing Integration
Matthew Brieger, the Chief Marketing Officer & Manager, External Manufacturing Integration at Astellas Pharma, directs the alignment of commercial marketing strategies with external manufacturing partnerships. Overseeing the integration of third-party production facilities, the Chief Marketing Officer & Manager, External Manufacturing Integration ensures that supply chain capacity meets global market demand. This leadership role involves managing complex vendor relationships to maintain quality standards while scaling production. By synchronizing manufacturing output with marketing forecasts, Matthew Brieger directly impacts the availability of essential medications. Furthermore, the Chief Marketing Officer & Manager, External Manufacturing Integration collaborates with internal teams to resolve logistical bottlenecks in the pharmaceutical supply chain. Through the optimization of external manufacturing networks, the Chief Marketing Officer & Manager, External Manufacturing Integration secures the operational foundation for commercial growth. Brieger drives efficiency by bridging the gap between production capabilities and market requirements.
Tomohiro Kusawake - Vice President, Chief of Staff for Research and Development, Head of CRDO Office
Tomohiro Kusawake, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office at Astellas Pharma, directs the administrative and strategic functions of the research division. Overseeing the CRDO office, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office ensures that R&D projects receive the necessary support to advance through clinical development. This leadership role involves managing the allocation of scientific resources to prioritize high-impact therapeutic breakthroughs. By streamlining the research pipeline, Tomohiro Kusawake directly impacts the innovation cycle of the company. Furthermore, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office facilitates communication between research teams and executive leadership to ensure alignment with long-term goals. Through the management of complex R&D operations, the Vice President, Chief of Staff for Research and Development, Head of CRDO Office accelerates the delivery of new treatments to patients.
Katsuyoshi Sugita - Chief People Officer
Katsuyoshi Sugita, the Chief People Officer at Astellas Pharma, directs the human capital strategy to foster a high-performance culture. Overseeing talent acquisition and organizational development, the Chief People Officer ensures that the workforce possesses the expertise required for pharmaceutical innovation. This leadership role involves designing programs that promote employee engagement and professional growth across global operations. By aligning human resources with corporate objectives, Katsuyoshi Sugita directly impacts the retention of top scientific and commercial talent. Furthermore, the Chief People Officer manages diversity and inclusion initiatives to build a collaborative environment. Through the implementation of robust performance management systems, the Chief People Officer drives organizational excellence. Sugita maintains a focus on building a resilient workforce capable of navigating the challenges of the pharmaceutical industry while supporting the mission of improving patient health through dedicated human capital management.
Samantha Yuen - Chief People Officer, Enterprise Programs Lead, Office of & Director, Level)
Samantha Yuen, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) at Astellas Pharma, directs enterprise-wide programs that enhance organizational effectiveness. Overseeing large-scale human capital initiatives, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) ensures that internal processes support the strategic goals of the company. This leadership role involves managing complex programs that integrate talent management with operational efficiency. By driving enterprise programs, Samantha Yuen directly impacts the agility of the organization in responding to market shifts. Furthermore, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) collaborates with leadership to standardize professional development across all departments. Through the execution of these enterprise-level programs, the Chief People Officer, Enterprise Programs Lead, Office of & Director, Level) fosters a unified corporate culture. Yuen maintains a focus on scaling human capital solutions to support global pharmaceutical operations.
Explore Leadership Teams in Manufacturing
RemeGen is a biopharmaceutical company focused on developing innovative drugs for autoimmune diseases and cancers. Their flagship products include Telitacicept, a dual-target fusion protein for autoimmune conditions, and Disitamab Vedotin, an antibody-drug conjugate for cancer treatment. The company has a robust product pipeline with numerous drugs in various stages of research and development. RemeGen aims to serve patients globally, leveraging its advanced technology and strong scientific support.
Company Leadership JF
JL
MS
KH
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership CO
BL
BL
ZW
Laurus Labs Limited is an Indian pharmaceutical and biotechnology company focused on the research, development, manufacturing, and commercialization of active pharmaceutical ingredients, finished dosage formulations, biotechnology products, and contract development and manufacturing services. Headquartered in Hyderabad, India, the company has evolved into one of the country's leading integrated pharmaceutical organizations, serving global healthcare markets through a combination of scientific innovation, manufacturing excellence, regulatory compliance, and strategic partnerships.
Company Leadership SC
RV
SP
SK pharmteco is a leading global contract development and manufacturing organization (CDMO) that specializes in drug development and manufacturing services for small molecules, biologics, cell, and gene therapies. The company offers a comprehensive range of services including API drug development, manufacturing, and regulatory support, catering to clients at every phase of their therapeutic programs. With a network of CGMP facilities, SK pharmteco empowers clients worldwide to bring innovative therapies to patients at any scale. Their commitment to seamless technology transfer and dedicated program management ensures successful project execution and regulatory compliance.
Company Leadership KM

DL